30 posts categorized "Dan Hussar"


Dr. Dan Hussar weighs in: Are business tactics at some pharmacies risking your health?"

Dr. Dan Hussar was interviewed for a story on KSDK in St. Louis about the pressure some pharmacists are under to fill prescription quotas while trying to balance patient care.
From the report:    
Dan Hussar is a nationally-known expert and teacher of pharmacology at Philadelphia’s University of the Sciences. He told 5 On Your Side that the pace and pressure of prescription quotas appear to be having an impact on accuracy.

Among other things, he points to figures from the U.S. Food and Drug Administration’s Adverse Event Reporting System. It shows reported medication errors have increased by 450% since 2010.

“The frequency of these errors is increasing greatly,” Dr. Hussar said. “I've heard some pharmacists say, ‘It's a blur as to what happened during the day and I can only pray I didn't make any serious mistakes.’"


Philadelphia Inquirer: Readers join the debate over what to call older people

Philadelphia Inquirer reporter Stacey Burling asked and readers answered. What word should be used to describe people over the age of 65? Dr. Dan Hussar wrote in saying he prefers “chronologically gifted.” 


KYW: Dr. Dan Hussar Weighs In on Grapefruit Drug Interactions

Dan Hussar was interviewed by KYW Newsradio’s Lynne Adkins about the FDA’s recent warning that grapefruit juice may cause drug interactions.


Nursing: New Drugs 2017, part 2

Dr. Dan Hussar P'62, MS’64, PhD’67 penned part two of his annual review of new drugs for the July edition of Nursing Magazine.   


Pennsylvania Pharmacist: Dr. Dan Hussar Honored at APhA Annual Meeting

Pennsylvania Pharmacist magazine honored Dr. Dan Hussar in their latest edition with an article and photo from the Remington Honor Medal award ceremony during the American Pharmacists Association’s annual meeting. (page 31)


Nursing Magazine: New Drugs 2017 by Dr. Dan Hussar

In the January edition of Nursing Magazine, Dr. Dan Hussar authored an article on new drugs recently approved by the FDA including the first drug approved to treat hyperkalemia in 50 years, a breakthrough drug for treating Parkinson’s, and an IV antiasthmatic medication indicated for add-on maintenance treatment in patients with severe asthma and an eosinophilic phenotype.

Access the full article here.


The Pharmacist Activist: Pharmacy fails drug interaction investigation

Dr. Dan Hussar’s latest edition of The Pharmacist Activist includes an opinion piece about pharmacists failing to notice drug interactions. Dr. Hussar’s warning to pharmacists stems from a December series in the Chicago Tribune about drug interactions and an investigation that found that pharmacists regularly failed to notify patients about potentially fatal drug interactions with common medications. Dr. Hussar also wrote an expert commentary about the issue, saying he is using the investigation as a teaching tool in his classes at Philadelphia College of Pharmacy.

Read the article from The Pharmacist Activist.


WOGL: PCP Prof Shares Compelling Journey with Cancer

Dr. Dan Hussar, pharmacy professor at University of the Sciences in Philadelphia, shared his compelling story of a diagnosis of acute myeloid leukemia, his continued recovery, and his former students who were on his medical treatment team at the Hospital of the University of Pennsylvania.

Listen to the audio at Audio: WOGL’s Philadelphia Agenda


Philadelphia Inquirer: New lesson: Pharmacists get to care for beloved mentor

Through the chemotherapy, through the loss of strength and appetite and the thoughts of mortality, pharmacy professor Dr. Daniel Hussar was repeatedly cheered by reunions with his former students in the six-year doctoral program. Only now, they were pharmacists on his treatment team in HUP's oncology unit. *This story ran on the front page of the health section on Sunday, Dec. 6.

Read more at New lesson: Pharmacists get to care for beloved mentor


Philadelphia Business Journal: The $1 million one-shot cure

Spark Therapeutics is expected to seek approval next year for a gene therapy to cure a disease that leads to blindness. Dr. Dan Hussar, a professor of pharmacy at the University of the Sciences, said multiple factors come into play when a pharmaceutical company sets a price for a new product—but no one standard method exists.

Read more at Philadelphia Business Journal: The $1 million one-shot cure